Rambam AG
Zugrambam.ch
Overview
Rambam AG is a Swiss-based venture studio and accelerator platform focused on breakthrough drug discovery and development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NeurOdys Therapeutics | Mar 2026 | Pre Seed | Lead |
Key People
Rouslan Michtchenko
Global Executive Director
Sanja Tomovska
Venture Partner Strategic Growth EU
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Rambam AG based?
Rambam AG is headquartered in Zug, Switzerland.
When was Rambam AG founded?
Rambam AG was founded in 2021.
How many portfolio companies does Rambam AG have?
Rambam AG has 1 portfolio company in Caplight's dataset.
What are some companies in Rambam AG's portfolio?
Portfolio companies visible on Caplight include NeurOdys Therapeutics.
What was Rambam AG's most recent investment shown here?
Rambam AG's most recent investment in this portfolio sample was in NeurOdys Therapeutics in 2026.
What sectors does Rambam AG focus on?
Rambam AG focuses on Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Rambam AG focus on?
Stage focus information for Rambam AG is not publicly available.
See something wrong or outdated?